{"id":"W2564757287","doi":"10.2217/fon-2016-0444","title":"Phase II Trial of Capecitabine Plus Erlotinib Versus Capecitabine Alone in Patients with Advanced Colorectal Cancer","year":2017,"lang":"en","type":"article","venue":"Future Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"Lions Gate Hospital; Centre Hospitalier de l’Université de Montréal; Cancer Care Ontario; Western University","funders":"","keywords":"Capecitabine; KRAS; Medicine; Erlotinib; Colorectal cancer; Internal medicine; Oncology; Tyrosine-kinase inhibitor; Gastroenterology; Cancer; Epidermal growth factor receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001183591,0.0002842988,0.001088867,0.0001149676,0.0002756497,0.000007620698,0.000166402,0.000183208,0.000265712],"category_scores_gemma":[0.0001483118,0.0002013212,0.0001007561,0.0001341103,0.0002745235,0.0001117138,0.0001302318,0.0002611309,0.000003289817],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000794879,"about_ca_system_score_gemma":0.0005234054,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004692053,"about_ca_topic_score_gemma":0.01030037,"domain_scores_codex":[0.9984325,0.00004949544,0.0004049485,0.0004126964,0.0003033565,0.0003970449],"domain_scores_gemma":[0.9987261,0.00009184662,0.0004177575,0.0003798603,0.0002563931,0.0001280512],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8193308,0.007596023,0.01489102,0.00004756494,0.0005206355,0.0001190496,0.001309128,0.000006509926,0.0003319672,0.00005249173,0.0008329457,0.1549619],"study_design_scores_gemma":[0.6889963,0.101419,0.1830203,0.00007669998,0.0003175932,0.000003355182,0.0003326244,0.00001355795,0.000385432,0.000004569258,0.02521912,0.0002114997],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9838446,0.0006546407,9.192424e-7,0.002209309,0.002895162,0.001917711,0.0001176884,0.00002488943,0.008335105],"genre_scores_gemma":[0.9974892,0.0002819044,0.0003530172,0.00007179285,0.0009089728,0.0004509006,0.00008527251,0.00002979649,0.0003291834],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1681293,"threshold_uncertainty_score":0.8209641,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01852905303029057,"score_gpt":0.3391485561134127,"score_spread":0.3206195030831221,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}